NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways

Oncogene

Volumn 29, Issue 15, 2010, Pages 2252-2261

  Liu, G ^a   Xirodimas, D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NEDD8 PROTEIN; PROTEIN MDM2; PROTEIN NUB1; PROTEIN P53; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

ANIMALS; CELL LINE, TUMOR; CYTOPLASM; HUMANS; KINETICS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN; UBIQUITINATION;

MURINAE;

EID: 77951073143     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.494     Document Type: Article

References (44)

1. Abida WM, Nikolaev A, Zhao W, Zhang W, Gu W. (2007). FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J Biol Chem 282: 1797-1804.
2. Boyd SD, Tsai KY, Jacks T. (2000). An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2: 563-568.
3. Brooks CL, Gu W. (2006). p53 ubiquitination: Mdm2 and beyond. Mol Cell 21: 307-315.
4. Budanov AV, Karin M. (2008). p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451-460.
5. Carter S, Bischof O, Dejean A, Vousden KH. (2007). C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol 9: 428-435.
6. Carter S, Vousden KH. (2009). Modifications of p53: competing for the lysines. Curr Opin Genet Dev 19: 18-24.
7. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR. (2005). PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309: 1732-1735.
8. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M et al. (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014.
9. Coutts AS, Adams CJ, La Thangue NB. (2009). p53 ubiquitination by Mdm2: a never ending tail? DNA Repair (Amst) 8: 483-490.
10. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR et al. (2006). DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-134.
11. Dohmesen C, Koeppel M, Dobbelstein M. (2008). Specific inhibition of Mdm2-mediated neddylation by Tip60. Cell Cycle 7: 222-231.
12. Geyer RK, Yu ZK, Maki CG. (2000). The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2: 569-573.
13. Green DR, Kroemer G. (2009). Cytoplasmic functions of the tumour suppressor p53. Nature 458: 1127-1130.
14. Hicke L, Schubert HL, Hill CP. (2005). Ubiquitin-binding domains. Nat Rev Mol Cell Biol 6: 610-621.
15. Hipp MS, Raasi S, Groettrup M, Schmidtke G. (2004). NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem 279: 16503-16510.
16. Hurley JH, Lee S, Prag G. (2006). Ubiquitin-binding domains. Biochem J 399: 361-372.
17. Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET. (2001). Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem 276: 46655-46660.
18. Kerscher O, Felberbaum R, Hochstrasser M. (2006). Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22: 159-180.
19. Kirkin V, Dikic I. (2007). Role of ubiquitin-and Ubl-binding proteins in cell signaling. Curr Opin Cell Biol 19: 199-205.
20. Kito K, Yeh ET, Kamitani T. (2001). NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem 276: 20603-20609.
21. Laine A, Topisirovic I, Zhai D, Reed JC, Borden KL, Ronai Z. (2006). Regulation of p53 Localization and Activity by Ubc13. Mol Cell Biol 26: 8901-8913.
22. Lee JT, Gu W. (2010). The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 17: 86-92.
23. Lee KAW, Zerivitz K, Akusjarvi G. (1994). Small-scale preparation of nuclear extracts from mammalian cells. In: JE Celis (ed). Cell Biology: A Laboratory Handbook vol. I. Academic Press (Elsevier): Oxford, UK, pp 668-673.
24. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6: 443-450.
25. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W. (2003). Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302: 1972-1975.
26. Lohrum MA, Woods DB, Ludwig RL, Balint E, Vousden KH. (2001). C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol 21: 8521-8532.
27. Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, Mouchel PL et al. (2009). Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8: 1571-1576.
28. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM. (2007). Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26: 923-934.
29. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. (2003). p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590.
30. Nikolaev AY, Li M, Puskas N, Qin J, Gu W. (2003). Parc: a cytoplasmic anchor for p53. Cell 10: 29-40.
31. Oh W, Lee EW, Sung YH, Yang MR, Ghim J, Lee HW et al. (2006). Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 281: 17457-17465.
32. Rabut G, Peter M. (2008). Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep 9: 969-976.
33. Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS et al. (2006). The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J Biol Chem 281: 20045-20054.
34. Speidel D, Helmbold H, Deppert W. (2006). Dissection of transcrip-tional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 25: 940-953.
35. Sundqvist A, Liu G, Mirsaliotis A, Xirodimas DP. (2009). Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep 10: 1132-1139.
36. Tanji K, Tanaka T, Kamitani T. (2005). Interaction of NUB1 with the proteasome subunit S5a. Biochem Biophys Res Commun 337: 116-120.
37. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M et al. (2008). Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10: 676-687.
38. Tatham MH, Rodriguez MS, Xirodimas DP, Hay RT. (2009). Detection of protein SUMOylation in vivo. Nat Protoc 4: 1363-1371.
39. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408: 307-310.
40. Welchman RL, Gordon C, Mayer RJ. (2005). Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 6: 599-609.
41. Xirodimas D, Saville MK, Edling C, Lane DP, Lain S. (2001a). Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20: 4972-4983.
42. Xirodimas DP. (2008). Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem Soc Trans 36: 802-806.
43. Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP. (2004). Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcrip-tional activity. Cell 118: 83-97.
44. Xirodimas DP, Stephen CW, Lane DP. (2001b). Cocompartmentaliza-tion of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Exp Cell Res 270: 66-77.